Plaintiffs Want Pfizer Celebrex Docs Unsealed

Law360, New York (June 9, 2009, 12:00 AM EDT) -- Plaintiffs in the securities fraud class action against Pfizer Inc. accusing the company of making materially false statements about a clinical study of blockbuster anti-inflammatory drug Celebrex have asked the court to overturn an order they claim allows “unwarranted sealing” of documents.

In a motion filed Monday in the U.S. District Court for the District of New Jersey, plaintiffs argued that the public’s right to access court documents trumps the “self-critical analysis privilege” that has allowed Pfizer to keep court documents such as class certification and...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.